Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis

被引:0
作者
Xiang-Hua Ye
Zhi-Bin Bu
Jie Feng
Ling Peng
Xin-Biao Liao
Xin-Li Zhu
Xiao-li Sun
Hao-Gang Yu
Dan-Fang Yan
Sen-Xiang Yan
机构
[1] Zhejiang University School of Medicine,Department of Radiotherapy, First Affiliated Hospital
[2] Zhejiang Hospital,Department of Hematology
[3] Southern Medical University,Department of Interventional Radiology, Nanfang Hospital
[4] Zhejiang University School of Medicine,Department of Thoracic Oncology, First Affiliated Hospital
来源
Molecular Biology Reports | 2014年 / 41卷
关键词
TP53; Polymorphism; Lung cancer; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
The previous published data on the association between TP53 codon 72, intron 6, and intron 3 16 bp polymorphisms and lung cancer risk remained controversial. This meta-analysis of literatures was performed to derive a more precise estimation of the relationship. 38 publications with 51 studies were selected for this meta-analysis, including 17,337 cases and 16,127 controls for TP53 codon 72 (from 43 studies), 2,201 cases and 2,399 controls for TP53 intron 6 (from four studies), and 4,322 cases and 4,558 controls for TP53 intron 3 16 bp (from four studies). When all the eligible studies were pooled into the meta-analysis of codon 72 polymorphism, there was significant association between lung cancer risk and codon 72 polymorphism in any genetic model (dominant model: OR = 1.13, 95 % CI 1.05–1.21; recessive model: OR = 1.14, 95 % CI 1.02–1.27; additive model: OR = 1.19, 95 % CI 1.05–1.33). In the subgroup analysis by ethnicity, histological type, source of control, and smoking status, significantly increased risks were observed in subgroups such as Asians, Caucasians, lung squamous cell carcinoma patients for Asians, population-based study, hospital-based study, non-smokers, and smokers. When all the eligible studies were pooled into the meta-analysis of intron 6 polymorphism, there was significant association between lung cancer risk and intron 6 polymorphism in dominant model (OR = 1.27, 95 % CI 1.11–1.44). When all the eligible studies were pooled into the meta-analysis of intron 3 16 bp polymorphism, there was significant association between lung cancer risk and intron 3 16 bp polymorphism in dominant model (OR = 1.12, 95 % CI 1.02–1.23) and additive model (OR = 1.41, 95 % CI 1.04–1.90). Additionally, when one study was deleted in the sensitive analysis, the results of TP53 intron 3 16 bp duplication polymorphism were changed in the dominant model (OR = 1.11, 95 % CI 0.87–1.42) and additive model (OR = 1.01, 95 % CI 0.65–1.56). In summary, this meta-analysis indicates that codon 72 and intron 6 polymorphisms show an increased lung cancer risk. A study with the larger sample size is needed to further evaluated gene-environment interaction on TP53 codon 72, intron 6, and intron 3 16 bp polymorphisms and lung cancer risk.
引用
收藏
页码:373 / 385
页数:12
相关论文
共 416 条
[1]  
Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90
[2]  
Bray F(2005)Epidemiology of lung cancer: looking to the future J Clin Oncol 23 3175-3185
[3]  
Center MM(1991)p53 mutations in human cancers Science 253 49-53
[4]  
Ferlay J(2003)Decision making by p53: life, death and cancer Cell Death Differ 10 431-442
[5]  
Ward E(2005)p53 guardian and suppressor of longevity? Exp Gerontol 40 7-9
[6]  
Forman D(2003)The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 33 357-365
[7]  
Alberg AJ(1994)Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines Hum Genet 93 620-624
[8]  
Brock MV(1993)Simple sequence repeat polymorphism within the p53 gene Oncogene 8 1703-1705
[9]  
Samet JM(1991)BstNI/NciI polymorphism of the human p53 gene (TP53) Nucleic Acids Res 19 6969-831
[10]  
Hollstein M(1994)Introns: evolution and function Curr Opin Genet Dev 4 823-483